[1]
Somase, K.P. 2024. Estimation of Remogliflozin Etabonate Active Pharmaceutical Ingredient by Reverse Phase High-Performance Liquid Chromatography Method and Characterization of its Degradation Products by Liquid Chromatography-Mass Spectrometry. Asian Journal of Pharmaceutics (AJP). 18, 01 (Mar. 2024). DOI:https://doi.org/10.22377/ajp.v18i01.5287.